Literature DB >> 1850256

The inhibitory activity of a peptide derivative against the growth of simian immunodeficiency virus in C8166 cells.

J A Martin1, M A Mobberley, S Redshaw, A Burke, A S Tyms, T A Ryder.   

Abstract

The peptide derivative Ro 31-8959 is a potent and selective inhibitor of the aspartic proteinases encoded by HIV-1 and HIV-2 and it arrests the growth of both viruses in cell culture. We have demonstrated similar effects against the simian immunodeficiency virus SIVmac251 in the human T-cell line, C8166 (ED50 = 6nM) with a therapeutic index of 4,500. The antiviral activity of Ro 31-8959 was 250 and 22 times greater than that of ddI and ddC, respectively. The mode of action was confirmed by accumulation of the polyprotein p55 with concomitant reduction of the cleavage product, p27, and by the production of immature virions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850256     DOI: 10.1016/0006-291x(91)90906-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Antiretroviral drug resistance in human immunodeficiency virus type 2.

Authors:  Michel L Ntemgwa; Thomas d'Aquin Toni; Bluma G Brenner; Ricardo J Camacho; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

2.  Xenotropic murine leukemia virus-related virus is susceptible to AZT.

Authors:  Ryuta Sakuma; Toshie Sakuma; Seiga Ohmine; Robert H Silverman; Yasuhiro Ikeda
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

3.  Effects of U-75875, a peptidomimetic inhibitor of retroviral proteases, on simian immunodeficiency virus infection in rhesus monkeys.

Authors:  L N Martin; K F Soike; M Murphey-Corb; R P Bohm; E D Roberts; T J Kakuk; S Thaisrivongs; T J Vidmar; M J Ruwart; S R Davio
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

4.  Genome-wide characterisation of the binding repertoire of small molecule drugs.

Authors:  Lee Makowski; Diane J Rodi
Journal:  Hum Genomics       Date:  2003-11       Impact factor: 4.639

5.  Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.

Authors:  Kevin Peterson; Sabelle Jallow; Sarah L Rowland-Jones; Thushan I de Silva
Journal:  AIDS Res Treat       Date:  2011-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.